Caldwell Trust
PFE icon

Caldwell Trust’s Pfizer PFE Stock Holding History

Caldwell Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.19M Sell
41,684
-2,455
-6% -$65.3K 0.09% 155
2026
Q2 		$1.06M Sell
44,139
-845
-2% -$22.1K 0.09% 165
2026
Q1 		$1.26M Sell
44,984
-361
-0.8% -$9.6K 0.11% 146
2025
Q4 		$1.13M Sell
45,345
-5,238
-10% -$132K 0.1% 154
2025
Q3 		$1.29M Sell
50,583
-2,029
-4% -$50.1K 0.12% 148
2025
Q2 		$1.28M Sell
52,612
-1,293
-2% -$30.2K 0.13% 143
2025
Q1 		$1.37M Sell
53,905
-2,371
-4% -$62K 0.15% 135
2024
Q4 		$1.49M Sell
56,276
-3,998
-7% -$108K 0.16% 123
2024
Q3 		$1.74M Sell
60,274
-4,052
-6% -$118K 0.18% 113
2024
Q2 		$1.8M Sell
64,326
-9,789
-13% -$270K 0.2% 100
2024
Q1 		$2.06M Sell
74,115
-13,435
-15% -$373K 0.24% 94
2023
Q4 		$2.52M Sell
87,550
-14,379
-14% -$435K 0.32% 71
2023
Q3 		$3.38M Sell
101,929
-4,935
-5% -$175K 0.46% 51
2023
Q2 		$3.92M Sell
106,864
-4,609
-4% -$179K 0.51% 49
2023
Q1 		$4.55M Sell
111,473
-1,407
-1% -$60.8K 0.63% 44
2022
Q4 		$5.78M Buy
112,880
+2,662
+2% +$128K 0.82% 37
2022
Q3 		$4.82M Sell
110,218
-87
-0.1% -$4.23K 0.72% 40
2022
Q2 		$5.78M Buy
110,305
+413
+0.4% +$21K 0.8% 36
2022
Q1 		$5.69M Sell
109,892
-196
-0.2% -$10.2K 0.68% 38
2021
Q4 		$6.5M Sell
110,088
-417
-0.4% -$20.7K 0.75% 34
2021
Q3 		$4.75M Buy
110,505
+20,880
+23% +$925K 0.6% 41
2021
Q2 		$3.51M Buy
89,625
+7,581
+9% +$295K 0.46% 53
2021
Q1 		$2.97M Buy
82,044
+6,786
+9% +$241K 0.41% 59
2020
Q4 		$2.77M Sell
75,258
-3,379
-4% -$124K 0.42% 57
2020
Q3 		$2.74M Sell
78,637
-216
-0.3% -$7.57K 0.45% 55
2020
Q2 		$2.45M Sell
78,853
-2,753
-3% -$93.5K 0.41% 61
2020
Q1 		$2.53M Sell
81,606
-1,287
-2% -$43.9K 0.48% 57
2019
Q4 		$3.08M Buy
+82,893
New +$2.95M 0.47% 62

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Caldwell Trust's PFE Position: Q3 2026 in Review

Caldwell Trust reduced its Pfizer (PFE) stake by 5.6% in Q3 2026, selling an estimated $65.3K and leaving 41,684 shares worth $1.19M. The position accounts for 0.09% of the portfolio, ranked #155.

Caldwell Trust first reported a position in PFE in Q4 2019 and has held it in 28 quarters since. The position peaked at $6.5M in Q4 2021. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Caldwell Trust held 41,684 shares of Pfizer worth $1.19M as of Q3 2026.
  • Caldwell Trust sold 2,455 Pfizer shares in Q3 2026, an estimated $65.3K.
  • Pfizer made up 0.09% of Caldwell Trust's portfolio in Q3 2026, its #155 holding.
  • Caldwell Trust first reported a position in Pfizer in Q4 2019 and has held it in 28 quarters since.
  • Caldwell Trust's Pfizer position peaked at $6.5M in Q4 2021.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.